A new kind of CRISPR that destroys cells rather than gene editing them has shown potential for killing sick cells while leaving healthy cells untouched. The technology has largely been tested in cells ...
Among the challenges in treating disease, including cancer, is wiping out malignancies, infection, contaminants or other ...
Researchers from Utah State University, University of Utah Health, the Helmholtz Institute for RNA-based Infection Research ...
When activated by its target, the newly characterized molecule rips the genome apart, a lethal move that researchers can ...
CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. “The first ...
A new kind of CRISPR that destroys cells rather than gene editing them has shown potential for killing sick cells while ...
Dr Giovanni Pietrogrande and Dr Tahmina Tabassum developed their new fusion protein at UQ's Australian Institute for ...
Cancer cells have ways to hide from the immune system, but there are some unique features on these dangerous cells that ...
IDT played a pivotal role in manufacturing the personalized gene editing therapy given to baby KJ Muldoon to treat his rare ...
An international research team from academia and industry publishes new findings on the nuclease Cas12a2 in the journal Nature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results